Contact this trialFirst, we need to learn more about you.
Anti-inflammatory Agent
Infliximab for Schizophrenia
Recruiting2 awardsPhase 4
Atlanta, Georgia
This trial will investigate the effects of an anti-inflammatory drug on negative symptoms of schizophrenia, with the goal of identifying new treatments.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.